Covered recipient · General Payments record
ANECIA J REYNOLDS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2024
$469.69
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $469.69 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $153.48 | 3 |
| JAZZ PHARMACEUTICALS INC. | $150.57 | 2 |
| Tris Pharma Inc | $79.88 | 5 |
| Corium, Inc. | $37.98 | 2 |
| Teva Pharmaceuticals USA, Inc. | $16.90 | 1 |
| Neos Therapeutics, LP | $16.04 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $14.84 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $469.69 | 15 |
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Corium, LLC | $19.00 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100210116 | CMS |
| Corium, LLC | $18.98 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100210110 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $14.84 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146306857 | CMS |
| JAZZ PHARMACEUTICALS INC. | $15.98 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151302180 | CMS |
| JAZZ PHARMACEUTICALS INC. | $134.59 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151302182 | CMS |
| Neos Therapeutics, LP | $16.04 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082665463 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.90 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151602573 | CMS |
| Tris Pharma Inc | $15.34 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147214897 | CMS |
| Tris Pharma Inc | $15.57 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147214899 | CMS |
| Tris Pharma Inc | $17.65 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147214903 | CMS |
| Tris Pharma Inc | $16.28 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147214901 | CMS |
| Tris Pharma Inc | $15.04 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147214895 | CMS |
| UCB, Inc. | $113.53 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143111946 | CMS |
| UCB, Inc. | $18.94 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143111948 | CMS |
| UCB, Inc. | $21.01 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143111950 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.